Join us for our new eSeminar, “Accelerating mRNA research and manufacturing” launching on 5 April 2022, from 9:00 AM-1:00 PM Singapore Time.
Like you, we know that therapies based on messenger RNA, such as mRNA vaccines, have revolutionary potential. mRNA-based therapies offer precise and individualized therapy. They avoid manufacturing issues associated with recombinant proteins. And, compared with current therapeutics, mRNA is more cost-effective, faster, and flexible to produce.
In this eSeminar, Danaher hosts multiple partner companies who share Solutions for large-scale production of mRNA-based molecules to help you address some of these challenges.
We look forward to engaging with you soon!